Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
1.
Actual. SIDA ; 18(67): 25-29, mar. 2010. tab
Article in Spanish | LILACS | ID: lil-566746

ABSTRACT

La determinación de la carga viral de HIV y la detección del ADN proviral en semen se utilizan en protocolos de fertilización para parejas discordantes (hombre HIV positivo - mujer AMPLICOR HIV-1 MONITOR tm Test versión 1.5 (Roche) en plasma seminal para estimar la carga viral. Se procesaron 31 muestras de plasma seminal, diluidas y sin diluir para evaluar la amplificación del control interno y descartar posibles inhibiciones. Luego se contaminaron 22 muestras con plasma de pacientes HIV positivos para verificar la cuantificación del ARN viral. Finalmente, se procesaron 12 muestras en paralelo por Nuclisens HIV-1 QT (Biomerieux) para descartar potenciales falsos negativos. Concluimos que el sistema evaluado es un método adecuado para cuantificar ARN viral en plasma seminal. No se observó inhibición, ni falsos negativos y los valores de carga viral y el límite de detección no se vieron modificados por la matriz diferente.


Analyses of the HIV load and presence of proviral DNA in sperm samples are used in assisted fertilization protocols for discordant couples (infected man-healthy woman). We evaluated the use of the COBAS Ampliprep/COBAS AMPLICOR HIV-1 MONITOR tm Test versión 1.5 (Roche) for viral load quantification in seminal plasma samples. We first tested 31 sperm samples for amplification of the internal control to discard potential inhibition. Seminal plasmas were analyzed directly and diluted. We then spiked 21 sperm samples with human plasma from HIV-positive patients to confirm that HIV RNA could be amplified. We also compared the results of 12 samples with NASBA (Nuclisens HIV-1 QT, Biomerieux), and confirmed lack of false negative results. We conclude that the new assay is an adequate methodology to analyze HIV load in sperm samples. We did not observed inhibition, neither false negative results and quantification demonstrated equivalent HIV loads.


Subject(s)
Humans , Male , Antiretroviral Therapy, Highly Active , DNA , Fertilization/immunology , HIV , Guidelines as Topic/methods , Reverse Transcriptase Inhibitors , Reverse Transcriptase Polymerase Chain Reaction , Semen/immunology , Nucleic Acid Amplification Techniques/methods , Viral Load
SELECTION OF CITATIONS
SEARCH DETAIL